A Study To Investigate And Describe The Treatment Patterns And Effect Of

See also
Status	Clinical Trial	Phase
Terminated	`NCT01682512` - Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis	Phase 3
Completed	`NCT00539760` - A Phase I Rheumatoid Arthritis Study in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT03312465` - Anatomical Shoulder Domelock System Study
Completed	`NCT01208181` - A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)	Phase 3
Completed	`NCT03254810` - Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects	Phase 1
Completed	`NCT01711814` - A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study	Phase 2
Completed	`NCT03315494` - Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers	Phase 1
Withdrawn	`NCT03241446` - Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)	Phase 1
Completed	`NCT02553018` - Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe	Phase 3
Completed	`NCT02748785` - MTX Discontinuation and Vaccine Response	Phase 4
Active, not recruiting	`NCT02260778` - Treat-to-target in RA: Collaboration To Improve adOption and adhereNce	N/A
Completed	`NCT02569736` - Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
Completed	`NCT01750931` - This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.	Phase 2
Withdrawn	`NCT01204138` - Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA	Phase 2
Not yet recruiting	`NCT01154647` - Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes	N/A
Completed	`NCT00973479` - An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy	Phase 3
Completed	`NCT00975130` - Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)	Phase 3
Completed	`NCT00913458` - Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis	Phase 4
Completed	`NCT00550446` - A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis	Phase 2
Completed	`NCT00660647` - Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)	Phase 3

NCT number	NCT04721808
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase
Start date	January 22, 2021
Completion date	November 24, 2021

A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms